Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) EPS (Basic): 2017-2025

Historic EPS (Basic) for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to $0.18.

  • Puma Biotechnology's EPS (Basic) fell 56.10% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 56.25%. This contributed to the annual value of $0.62 for FY2024, which is 34.78% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's EPS (Basic) is $0.18, which was up 50.00% from $0.12 recorded in Q2 2025.
  • Puma Biotechnology's EPS (Basic)'s 5-year high stood at $0.41 during Q1 2021, with a 5-year trough of -$1.09 in Q3 2021.
  • Over the past 3 years, Puma Biotechnology's median EPS (Basic) value was $0.12 (recorded in 2025), while the average stood at $0.13.
  • In the last 5 years, Puma Biotechnology's EPS (Basic) spiked by 1,300.00% in 2023 and then crashed by 433.33% in 2024.
  • Puma Biotechnology's EPS (Basic) (Quarterly) stood at $0.10 in 2021, then tumbled by 230.00% to -$0.13 in 2022, then surged by 300.00% to $0.26 in 2023, then soared by 50.00% to $0.39 in 2024, then slumped by 56.10% to $0.18 in 2025.
  • Its EPS (Basic) was $0.18 in Q3 2025, compared to $0.12 in Q2 2025 and $0.06 in Q1 2025.